Medicines NZ is the industry association representing companies engaged in the research, development, manufacture and marketing of modern prescription medicines
🚀 Applications for the Value of Medicines Innovation Jump Start Award are now OPEN!
Are you an early career researcher of innovative medicines or vaccines? If so, we want to hear from you!
🔗https://t.co/PqkRjcEPkr
#ValueofMedicines
Medicines New Zealand is pleased to announce the 2022 Value of Medicines Awards recipients.
Congratulations to Dr Emma Wade, recipient of the Innovation Jump Start Award & Professor Richard Robson, recipient of the Excellence in Innovative Medicines Research Award.
Intellectual property fuels the entire innovation system, helping researchers from universities, small biotechs and pharma companies deliver more health breakthroughs. #IPMakesItHappen@IFPMA
Intellectual property prompts researchers and companies to risk time and money to develop a variety of cutting-edge technologies that could be used for the next health crisis. #IPMakesItHappen@IFPMA
Intellectual property supported decades of research and innovation, instrumental in delivering the vaccines and medicines to tackle the COVID-19 pandemic. #IPMakesItHappen@IFPMA
Intellectual property enables pharma companies to collaborate and voluntarily share knowledge with trusted partners to scale up the production of breakthrough medicines and vaccines. #IPMakesItHappen@IFPMA
Intellectual property spurs on researchers and companies to pursue new medicines by providing a framework that helps manage the risks, costs and time involved in developing them. #IPMakesItHappen@IFPMA
Intellectual property boosts research and encourages the sharing of inventions that bring life-saving innovations to those in need. #IPMakesItHappen@IFPMA
We know mRNA vaccines can help provide protection against COVID-19. Now we’re using that breakthrough to explore how it could offer new hope for other diseases like flu, cancer, TB and malaria. Learn how we’re #AlwaysInnovating https://t.co/5eb5p0zvkw #TeamVaccines
COVID-19 taught us many lessons. Science and production delivered, but efforts to achieve equitable access must continue. We’re working on solutions for when the next outbreak happens. Learn how we’re #AlwaysInnovating https://t.co/7NmKwMwN3F #TeamVaccines
What are the foundational prerequisites of a future pandemic preparedness system?
Our vision for equitable access in pandemics ➡️https://t.co/l1mWvrh8lM
@IFPMA
We recently announced the biopharmaceutical industry’s vision for equitable access in pandemics.
What are the implementation priorities and how can we shape a future where everyone is better protected from the threat of pandemics?
https://t.co/l1mWvrh8lM
@IFPMA
The adoption of #AI in healthcare holds the promise for advances in treatments and patient experiences. Realizing this potential can be done through the adoption of these ethics principles: https://t.co/F4esLIoOpm
Science & #innovation delivered against #COVID19. But to be better prepared ahead of future threats, we need a collaborative solution for more equitable rollout of vaccines, treatments & diagnostics. #C19LessonsLearned
Read the Berlin Declaration:
https://t.co/l1mWvrh8lM
@IFPMA
Together with our partners, we’re working hard so that people can benefit from #COVID19 vaccines, proven to be safe and effective, wherever they live in the world. #TeamVaccines#AlwaysInnovating https://t.co/5eb5p0zvkw
Equitable access requires more than the delivery of doses. To strive for #COVID19 vaccine equity, innovative biopharmaceutical companies are committed to prioritizing:
🌏Country Readiness
⚙️Equitable Distribution
💡Innovation
➡️https://t.co/Akz5XgIOip
Today Medicines New Zealand presented to the Pae Ora Legislation Committee on the Pae Ora (Healthy Futures) Bill.
Click on the link below and fast forward the video to 10.55 minutes to listen to our submission.
https://t.co/XOv6tXbXIy
#medicinesaccess#innovation#PaeOra
The Medicines New Zealand office will be closed from Friday 24 December 2021 and will reopen on Monday 10 January 2022.
For media enquiries during this period please call or text 027 534 6461 and we will endeavour to get back to you as soon as possible.
Happy Holidays!